UnitedHealth Group Incorporated $UNH Shares Sold by Skandinaviska Enskilda Banken AB publ

Skandinaviska Enskilda Banken AB publ cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 26.2% in the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 326,494 shares of the healthcare conglomerate’s stock after selling 115,807 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in UnitedHealth Group were worth $101,856,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of UNH. Norges Bank acquired a new position in UnitedHealth Group during the 2nd quarter valued at approximately $3,837,207,000. Measured Wealth Private Client Group LLC increased its position in shares of UnitedHealth Group by 11.9% in the 2nd quarter. Measured Wealth Private Client Group LLC now owns 1,573 shares of the healthcare conglomerate’s stock valued at $491,000 after acquiring an additional 167 shares during the period. Patient Capital Management LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth about $59,877,000. Crake Asset Management LLP acquired a new position in shares of UnitedHealth Group in the second quarter valued at about $35,547,000. Finally, Quadrature Capital Ltd lifted its holdings in shares of UnitedHealth Group by 6,493.3% during the second quarter. Quadrature Capital Ltd now owns 568,869 shares of the healthcare conglomerate’s stock worth $177,328,000 after purchasing an additional 560,241 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $329.78 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The company’s fifty day moving average price is $343.51 and its 200 day moving average price is $315.21. The stock has a market capitalization of $298.73 billion, a P/E ratio of 17.21, a P/E/G ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $622.83.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same quarter last year, the business earned $7.15 earnings per share. The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on UNH. Royal Bank Of Canada raised their price target on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Piper Sandler lowered their price target on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a report on Tuesday, October 28th. The Goldman Sachs Group assumed coverage on UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 price objective for the company. Finally, Morgan Stanley raised their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.